Daniel Solomon, MD, MPH, is a Professor of Medicine at Harvard Medical School and Chief of the Section of Clinical Sciences in Rheumatology and is co-appointed in the Division of Pharmacoepidemiology and Pharmacoeconomics. The focus of his research is health services research, quality of care, and pharmacoepidemiology as it pertains to rheumatic diseases and osteoporosis. Specific topics of interest include: indicators of quality prescribing, patterns of medication use for osteoporosis, quality improvement in osteoporosis care, and cardiovascular disease in patients with rheumatoid arthritis. Dr. Solomon is Chair of the Quality of Care Committee of the American College of Rheumatology and was awarded the Henry Kunkel Young Investigator Award from the ACR in 2007. He attended Yale College, Yale School of Medicine, and Harvard School of Public Health. His residency and fellowship training in rheumatology were completed at Brigham and Women’s Hospital. As well, his clinical practice is at Brigham and Women’s Hospital.
.png)
